Related Experiment Video
Updated: Jul 17, 2026

Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
Published on: April 5, 2011
[Prospective long-term ECG study of 100 patients surviving sudden cardiac death]
J Herms1, J Siebels, M Schneider
1Abteilung für Kardiologie der II. Medizinischen Klinik, Universitätskrankenhaus Eppendorf, Hamburg.
Insights
Sudden cardiac death survivors treated with Amiodarone or Metoprolol showed reduced relapse rates. Ventricular ectopic activity
Area of Science:
- Cardiology
- Clinical Electrophysiology
Background:
- Sudden cardiac death (SCD) survivors often exhibit ventricular ectopic activity.
- The prognostic significance of this activity can be influenced by antiarrhythmic treatment.
Purpose of the Study:
- To evaluate the impact of different antiarrhythmic drugs and an automatic implantable cardioverter/defibrillator (AICD) on ventricular ectopic activity and arrhythmia relapse in SCD survivors.
Main Methods:
- 100 SCD survivors were randomized into four groups: Amiodarone, Propafenone, Metoprolol, or AICD (control).
- Prospective Holter-monitoring was used to assess ventricular ectopic activity (frequency and complexity).
- Two-year relapse rates for life-threatening ventricular tachyarrhythmias were recorded.
Main Results:
- Frequent and complex ventricular ectopic activity predicted relapse in the AICD control group (>= 25 VES/h).
- Amiodarone significantly reduced ventricular ectopic activity and the 2-year relapse rate (12%) compared to AICD (36%).
- Metoprolol increased ectopic activity but also reduced relapse rates (12%), while Propafenone showed a high relapse rate (28%) in patients with low ectopic activity.
Conclusions:
- Prophylactic antiarrhythmic treatment significantly modifies the prognostic value of ventricular ectopic activity in SCD survivors.
- Amiodarone and Metoprolol demonstrate efficacy in reducing relapse rates, with Amiodarone also decreasing ectopic activity.
- Propafenone may pose a risk for certain patient subgroups, highlighting the need for personalized treatment strategies.
Abstract:
One hundred survivors of sudden death were randomized to four groups and treated with Amiodarone, Propafenone and Metoprolol, or were supplied with an automatic implantable cardioverter/defibrillator (AICD, control group). Prospective Holter-monitoring showed that the prognostic significance of the complexity and frequency of ventricular ectopic activity in survivors of sudden cardiac death is relative to the chosen prophylactic antiarrhythmic treatment: Findings in the control group confirm the classical notion that frequent and complex ventricular ectopic activity is predictive for recurrent life-threatening ventricular tachyarrhythmias (relapse) (> or = 25 VES/h, p < 0.05; Lown IVb, just short of statistical significance). Therapy with Amiodarone reduced frequent and complex ventricular ectopic activity as well as the 2-year relapse rate, which was significantly lower than in the control group (AICD: 36%, Amiodarone 12%, p = 0.03). Under Metoprolol the frequency and complexity of ectopic ventricular activity increased, yet the relapse rate was reduced (12%, p = 0.03). Under Propafenone, especially, those patients who showed low frequencies of ventricular ectopic activity were at high risk; the 2-year relapse rate was 28%.
More Related Videos
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
10:17Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
Published on: April 11, 2025
Related Concept Videos
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
Electrocardiogram
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and the T...
Cardiac Action Potential
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
Acute Coronary Syndrome III: Diagnostic Studies
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy